Spots Global Cancer Trial Database for stage iii squamous cell carcinoma of the head and neck
Every month we try and update this database with for stage iii squamous cell carcinoma of the head and neck cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pembrolizumab + N-803 Alone or in Combination With PD-L1 t-haNK Cells for Resectable Head and Neck Squamous Cell Carcinoma | NCT06161545 | Stage II Squamo... Stage III Squam... Stage IV Squamo... | N-803 pembrolizumab PD-L1 t-haNK ce... | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) |